Search clinical trials for: Biguard sirolimus-eluting bifurcation stent system

Total 283 results

CID S.p.A.

Unknown

Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

Coronary Artery Disease

China
Beijing AmsinoMed Medical Device Co., Ltd

Unknown

To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization

Myocardial Ischemia | Coronary Disease | Acute Coronary Syndrome | Ischemic Heart Disease

China
R&D Cardiologie
Biotronik SE & Co. KG

Unknown

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium
Marco Valgimigli

Unknown

Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI

Myocardial Infarction

Italy
Takeshi Morimoto

Completed

NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial (NEXT)

Coronary Artery Disease

Japan
Instituto Nacional de Cardiologia Ignacio Chavez

Recruiting

Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus (INC-DM)

Coronary Artery Disease | Diabetes Mellitus | Acute Coronary Syndrome

Mexico
Sahajanand Medical Technologies Pvt. Ltd.

Completed

Supralimus-Core™ Pharmacokinetic (PK) Study

Coronary Artery Disease

India
Beijing Anzhen Hospital

Unknown

The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions

Coronary Heart Disease
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) (LONG-DES-III)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Medtronic Vascular

Completed

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions (ZEST)

Coronary Artery Disease

Korea, Republic of
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China
Zhejiang Zylox Medical Device Co., Ltd.
Guangzhou Osmunda Medical Device Technology, Inc., Ltd.

Unknown

Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion

Peripheral Arterial Disease | Superficial Femoral Artery Occlusion | Superficial Femoral Artery Stenosis

China
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Universitaire Ziekenhuizen KU Leuven
Biosensors International

Unknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study (COBRA)

True Coronary Bifurcation Lesions

Belgium
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors Europe SA

Unknown

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII (SORT-OUT VIII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Genoss Co., Ltd.

Recruiting

Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

Coronary Artery Disease | Drug-eluting Stent

Korea, Republic of
Johns Hopkins University

Terminated

Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device

Thoracoabdominal Aortic Aneurysm

United States
Sino Medical Sciences Technology Inc.
Beijing Tiantan Hospital

Completed

First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial) (NOVA)

Ischemic Stroke

China
Robbert J de Winter

Unknown

Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent (REMEDEE Reg)

Coronary Artery Disease

Netherlands, Latvia, United Kingdom, Luxembourg, Spain
Medinol Ltd.

Completed

BIONICS Israel Trial

Stenosis

Israel
A.O. Ospedale Papa Giovanni XXIII
Medtronic Vascular; Case Western Reserve University

Unknown

Optical Coherence Tomography in Long Lesions (LONG OCT)

Coronary Artery Disease

Italy
Deutsches Herzzentrum Muenchen

Completed

Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

Coronary Heart Disease

Germany
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging

Coronary Artery Disease

Japan
InspireMD

Terminated

MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction (e-MASTER)

ST Elevation Myocardial Infarction

Netherlands
Charite University, Berlin, Germany
Techniker Krankenkasse

Completed

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents (GERSHWIN)

Coronary Artery Disease

Germany
Medinol Ltd.

Not yet recruiting

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease (CHAMPIONSHIP)

Popliteal Artery Stenosis | Superficial Femoral Artery Stenosis
ReFlow Medical, Inc.

Not yet recruiting

A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)

In-stent Restenosis
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Instituto Nacional de Cardiologia Ignacio Chavez

Terminated

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty (DEBORA)

Coronary Artery Disease (CAD) | Percutaneous Coronary Intervention (PCI) | High Bleeding Risk

Mexico
Beijing Tiantan Hospital
Alain Medical (Beijing) Co., Ltd.

Recruiting

Evaluating the Safety and Efficacy of the Maurora® DES in ICAS (Maurora ICAS)

Intracranial Arteriosclerosis | Stroke (CVA) or TIA

China
Seung-Jung Park
Cordis Corporation; CardioVascular Research Foundation, Korea

Terminated

Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients (ZEST-AMI)

Myocardial Infarction

Korea, Republic of
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Myocardial Infarction (RaCES-MI)

Acute Myocardial Infarction

Italy
Deutsches Herzzentrum Muenchen

Completed

3 Limus Agent Eluting Stents With Different Polymer Coating (ISAR-TEST-4)

Coronary Heart Disease

Germany
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
Medtronic Vascular

Completed

PROTECT Continued Access Post Marketing Surveillance Trial (PROTECT-CA)

Coronary Artery Disease, Autosomal Dominant, 1

United States
Medtronic Vascular
Medtronic Bakken Research Center

Completed

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population (R-Int)

Cardiovascular Diseases | Coronary Artery Disease

Germany
Meril Life Sciences Pvt. Ltd.

Unknown

Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. (Morph RCT-1)

Coronary Artery Disease
Harbin Medical University

Unknown

Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus

Coronary Artery Disease | Diabetes Mellitus

China
Antwerp Cardiovascular Institute Middelheim

Completed

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

Coronary Artery Disease | Stable Angina | Unstable Angina | Saphenous Vein Graft Disease

Belgium
Aarhus University Hospital Skejby
Biotronik SE & Co. KG; OrbusNeich

Active, not recruiting

SORT OUT X - Combo Stent Versus ORSIRO Stent (SORT OUT X)

Myocardial Infarction | Angina Pectoris | Coronary Heart Disease

Denmark
Jacobs institute

Not yet recruiting

An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke

Acute Ischemic Stroke
Harbin Medical University

Unknown

Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT (DM-COVER)

Diabetes Mellitus | Coronary Heart Disease

China
University Hospital Inselspital, Berne
University of Bern; Biotronik AG

Completed

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris

Switzerland
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) (PROTECT)

Ischemic Heart Disease

Netherlands
Deutsches Herzzentrum Muenchen

Completed

The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis (ISAR-TEST-2)

Coronary Disease

Germany

Search clinical trials for: Biguard sirolimus-eluting bifurcation stent system

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations